^
Association details:
Biomarker:No biomarker
Cancer:Thymic Carcinoma
Regimen:CAP (cisplatin + cyclophosphamide + doxorubicin hydrochloride)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Thymic Carcinoma: Other Recommended...CAP with Prednisone